$0.23 EPS Expected for Exactech, Inc. (EXAC)

October 29, 2017 – By Richard Conner

 $0.23 EPS Expected for Exactech, Inc. (EXAC)

Analysts await Exactech, Inc. (NASDAQ:EXAC) to report earnings on October, 30. They expect $0.23 earnings per share, up 4.55 % or $0.01 from last year’s $0.22 per share. EXAC’s profit will be $3.30M for 45.49 P/E if the $0.23 EPS becomes a reality. After $0.33 actual earnings per share reported by Exactech, Inc. for the previous quarter, Wall Street now forecasts -30.30 % negative EPS growth. It closed at $41.85 lastly. It is up 21.62% since October 29, 2016 and is uptrending. It has outperformed by 4.92% the S&P500.

Exactech, Inc. (NASDAQ:EXAC) Ratings Coverage

Among 4 analysts covering Exactech (NASDAQ:EXAC), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Exactech had 8 analyst reports since August 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, October 24 by Gabelli. As per Friday, September 4, the company rating was upgraded by Zacks. The stock of Exactech, Inc. (NASDAQ:EXAC) earned “Hold” rating by Robert W. Baird on Monday, October 23. The company was upgraded on Wednesday, April 13 by Robert W. Baird. The rating was maintained by Gabelli with “Buy” on Monday, July 31. The rating was maintained by Northland Capital with “Market Perform” on Wednesday, October 28. Robert W. Baird maintained the shares of EXAC in report on Friday, October 13 with “Buy” rating. The stock of Exactech, Inc. (NASDAQ:EXAC) has “Sell” rating given on Friday, August 21 by Zacks.

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The company has market cap of $600.47 million. The Company’s divisions include knee, hip, biologics and spine, extremity and other products. It has a 1093.26 P/E ratio. The Company’s other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

More notable recent Exactech, Inc. (NASDAQ:EXAC) news were published by: Streetinsider.com which released: “Sidoti Downgrades Exactech Inc (EXAC) to Neutral Following Acquisition” on October 23, 2017, also Prnewswire.com with their article: “EXACTECH INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn …” published on October 26, 2017, Prnewswire.com published: “SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of …” on October 26, 2017. More interesting news about Exactech, Inc. (NASDAQ:EXAC) were released by: Businesswire.com and their article: “EXACTECH, INC. SHAREHOLDER ALERT: Rigrodsky & Long, PA Announces Investigation …” published on October 23, 2017 as well as Businesswire.com‘s news article titled: “The Law Offices of Vincent Wong Notifies Investors of an Investigation of …” with publication date: October 25, 2017.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.